about
Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model ApproachAction mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studiesAcute exposure to air pollution particulate matter aggravates experimental myocardial infarction in mice by potentiating cytokine secretion from lung macrophagesExpression of vascular cell adhesion molecule-1 in the aortic tissues of atherosclerotic patients and the associated clinical implications.Abnormal expression of long non-coding RNAs in myocardial infarction.Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.
P2860
Q26782745-597B69DB-EAF3-4E84-857B-57C8D978AA15Q28077812-B6AE808B-7B2A-48D3-B2E5-78118468D899Q28395506-763F5F7D-6110-4064-B414-D467DEC88DB7Q35870501-2377D444-B44F-4241-83C9-E7119C1A4CC7Q38433257-4C57585D-59DD-49F5-8485-5161A1822C4BQ42011392-DDE3AA26-1DC1-41F8-A4BC-DF2258E60FA5Q51507063-B8DE0B34-5629-45C4-BA37-DE7E17187FDE
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammatory mechanisms in atherosclerosis.
@en
type
label
Inflammatory mechanisms in atherosclerosis.
@en
prefLabel
Inflammatory mechanisms in atherosclerosis.
@en
P356
P1433
P1476
Inflammatory mechanisms in atherosclerosis
@en
P2093
P356
10.5482/HAMO-13-09-0050
P577
2013-12-17T00:00:00Z